Celldex Therapeutics Inc CLDX:NASDAQ

Last Price$28.69NASDAQ Previous Close - Last Trade as of 4:00PM ET 6/28/22

Today's Change-0.45(1.54%)
Bid (Size)N/A (N/A)
Ask (Size)N/A (N/A)
Day Low / High$28.02 - 29.55
Volume827.2 K

View Medical Specialties IndustryPeer Comparison as of 06/28/2022


Celldex Therapeutics Inc ( NASDAQ )

Price: $28.69
Change: -0.45 (1.54%)
Volume: 827.2 K
4:00PM ET 6/28/2022

Silk Road Medical Inc ( NASDAQ )

Price: $37.52
Change: -1.19 (3.07%)
Volume: 150.4 K
4:00PM ET 6/28/2022

Avanos Medical Inc ( NYSE )

Price: $26.69
Change: -0.07 (0.26%)
Volume: 237.4 K
7:00PM ET 6/28/2022

CareDx Inc ( NASDAQ )

Price: $21.92
Change: -1.57 (6.68%)
Volume: 716.3 K
4:00PM ET 6/28/2022

Atrion Corp ( NASDAQ )

Price: $624.92
Change: -20.07 (3.11%)
Volume: 3.7 K
4:00PM ET 6/28/2022

Read more news Recent News

Celldex Therapeutics Says First Patient Dosed in Phase 2 Clinical Trial of Investigational Chronic Skin Disorder Treatment
11:11AM ET 6/21/2022 MT Newswires

Celldex Therapeutics (CLDX) said Tuesday it has dosed the first patient in the phase 2 clinical trial of its investigational treatment, barzolvolimab, in...

-- Earnings Flash (CLDX) CELLDEX THERAPEUTICS Posts Q1 Loss $-0.49
4:15PM ET 5/05/2022 MT Newswires


-- Earnings Flash (CLDX) CELLDEX THERAPEUTICS Posts Q1 Revenue $0.2M
4:14PM ET 5/05/2022 MT Newswires


-- Earnings Flash (CLDX) CELLDEX THERAPEUTICS Reports Q4 Revenue $0.3M
4:06PM ET 2/28/2022 MT Newswires


Company Profile

Business DescriptionCelldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ. View company web site for more details
AddressPerryville III Building
Hampton, New Jersey 08827
Number of Employees137
Recent SEC Filing06/23/20228-K
President, Chief Executive Officer & DirectorAnthony S. Marucci
CFO, Secretary, Treasurer & Senior Vice PresidentSam Martin
Chief Scientific Officer & Executive VPTibor Keler
Chief Medical Officer & Senior Vice PresidentDiane C. Young

Company Highlights

Price Open$29.17
Previous Close$28.69
52 Week Range$19.85 - 57.20
Market Capitalization$1.3 B
Shares Outstanding46.8 M
SectorHealth Technology
IndustryMedical Specialties
Next Earnings Announcement08/04/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.69
Beta vs. S&P 500N/A
Revenue$9.5 M
Net Profit Margin-1,860.01%
Return on Equity-21.45%

Analyst Ratings as of 09/16/2021

Consensus RecommendationConsensus Icon
Powered by Factset